Regulatory management option analysis
The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.
For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.
Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.
The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.
RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.
Further information
Last updated 23 December 2020. Database contains 260 unique substances/entries.
204-126-9 | 116-14-3 | Ireland | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | CLH | 05/12/2018 | Details | |
202-051-6 | 91-22-5 | Ireland | Carcinogenic Mutagenic Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 10/07/2015 | Details | |
205-355-7 | 139-13-9 | Ireland | Carcinogenic Mutagenic Toxic for reproduction | Under development | Under development | No suggestion yet | 12/01/2017 | Details | |
242-555-3 | 18755-43-6 | Ireland | Carcinogenic Mutagenic Toxic for reproduction | Pending | On hold | No suggestion yet | 24/09/2019 | Details | |
234-829-6 | 12035-72-2 | Hungary | Carcinogenic Mutagenic Skin sensitiser Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 12/05/2017 | Details | |
242-060-2 | 18172-67-3 | Greece | Respiratory sensitiser Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | CLH | 05/07/2017 | Details | |
215-535-7 | 1330-20-7 | Germany | Carcinogenic Mutagenic Respiratory sensitiser STOT RE Toxic for reproduction | Under development | Under development | No suggestion yet | 24/06/2020 | Details | |
- | - | Germany | Carcinogenic Endocrine disruption Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC Restriction | 17/01/2020 | Details | |
206-196-6 | 307-24-4 | Germany | Other environmental toxicity | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 25/11/2020 | Details | |
206-203-2 | 307-55-1 | Germany | Bioaccumulation Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 07/03/2017 | Details | |
203-726-8 | 109-99-9 | Germany | Carcinogenic Mutagenic Respiratory sensitiser STOT RE Toxic for reproduction | Under development | Under development | No suggestion yet | 24/06/2020 | Details | |
905-588-0 | - | Germany | Carcinogenic Mutagenic Respiratory sensitiser STOT RE Toxic for reproduction | Under development | Under development | No suggestion yet | 24/06/2020 | Details | |
905-562-9 | - | Germany | Carcinogenic Mutagenic Respiratory sensitiser STOT RE Toxic for reproduction | Under development | Under development | No suggestion yet | 24/06/2020 | Details | |
204-927-3 | 129-00-0 | Germany | Bioaccumulation Carcinogenic Mutagenic Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 05/07/2017 | Details | |
Covering any individual isomers and / or combinations thereof. show/hide | - | - | Germany | Endocrine disruption Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC Restriction | 25/11/2020 | Details |
201-581-5 | 85-01-8 | Germany | Bioaccumulation Carcinogenic Mutagenic Other environmental toxicity Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 05/07/2017 | Details | |
show/hide | - | - | Germany | Bioaccumulation Persistence Toxic for reproduction Widespread use | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 08/07/2019 | Details |
206-801-3 | 375-95-1 | Germany | Bioaccumulation Other environmental toxicity Persistence | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 07/03/2017 | Details | |
231-512-4 | 7601-90-3 | Germany | Endocrine disruption | Under development | Under development | No suggestion yet | 13/06/2016 | Details | |
276-745-2 | 72629-94-8 | Germany | Respiratory sensitiser Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 07/03/2017 | Details | |
203-396-5 | 106-42-3 | Germany | Carcinogenic Mutagenic Respiratory sensitiser STOT RE Toxic for reproduction | Under development | Under development | No suggestion yet | 24/06/2020 | Details | |
201-280-9 | 80-46-6 | Germany | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 07/03/2017 | Details | |
D4 | 209-136-7 | 556-67-2 | Germany | Aggregated tonnage Bioaccumulation Exposure Other environmental toxicity Persistence | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 05/01/2018 | Details |
202-422-2 | 95-47-6 | Germany | Carcinogenic Mutagenic Respiratory sensitiser STOT RE Toxic for reproduction | Under development | Under development | No suggestion yet | 24/06/2020 | Details | |
227-534-9 | 5873-54-1 | Germany | Respiratory sensitiser Skin sensitiser Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
206-400-3 | 335-76-2 | Germany | Bioaccumulation Other environmental toxicity Persistence | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 25/01/2019 | Details | |
231-714-2 | 7697-37-2 | Germany | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | CLH | 23/09/2014 | Details | |
240-841-2 | 16812-54-7 | Germany | Carcinogenic Mutagenic Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 12/05/2017 | Details | |
203-777-6 | 110-54-3 | Germany | Carcinogenic Mutagenic Respiratory sensitiser STOT RE Toxic for reproduction | Under development | Under development | No suggestion yet | 24/06/2020 | Details | |
225-625-8 | 4979-32-2 | Germany | Bioaccumulation Exposure Persistence Widespread use | Under development | Under development | No suggestion yet | 28/02/2019 | Details | |
203-576-3 | 108-38-3 | Germany | Carcinogenic Mutagenic Respiratory sensitiser STOT RE Toxic for reproduction | Under development | Under development | No suggestion yet | 24/06/2020 | Details | |
212-485-8 | 822-06-0 | Germany | Endocrine disruption Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
206-803-4 | 376-06-7 | Germany | Bioaccumulation Other environmental toxicity Persistence | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 07/03/2017 | Details | |
218-165-4 | 2058-94-8 | Germany | Bioaccumulation Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 07/03/2017 | Details | |
205-912-4 | 206-44-0 | Germany | Bioaccumulation Carcinogenic Mutagenic Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 05/07/2017 | Details | |
D5 | 208-764-9 | 541-02-6 | Germany | Bioaccumulation Other environmental toxicity Persistence | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 05/01/2018 | Details |
205-923-4 | 218-01-9 | Germany | Bioaccumulation Carcinogenic Mutagenic Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 05/07/2017 | Details | |
show/hide A mixture of: propan-2-one-O,O'(methoxyvinylsilandiyl)dioxime; propan-2-one-O-(dimethoxyvinylsilyl)oxime; propan-2-one-O,O',O''-(vinylsilantriyl)trioxime EC / List no: 458-680-3 | CAS no: 797751-44-1 A mixture of: propan-2-one-O,O'-(methoxymethylsilandiyl)dioxime; propan-2-one-O-(dimethoxymethylsilyl)oxime; propan-2-one-O,O',O''-(methylsilantriyl)trioxime EC / List no: 460-110-3 | CAS no: - 2-Propanone, 2,2',2''-[O,O',O''-(ethylsilylidyne)trioxime] EC / List no: 611-631-1 | CAS no: 58190-57-1 | - | - | Germany | Carcinogenic | Under development | Under development | No suggestion yet | 02/06/2020 | Details |
223-445-4 | 3896-11-5 | Germany | Carcinogenic Mutagenic Toxic for reproduction | Under development | Under development | No suggestion yet | 05/12/2014 | Details | |
show/hide disodium bis[(oxoboranyl)oxy]bicyclo[5.5.1]hexaboroxane-3,5-bis(olate) EC / List no: 602-894-3 | CAS no: 12280-03-4 | - | - | Germany | Toxic for reproduction | Under development | Under development | No suggestion yet | 15/07/2020 | Details |
231-150-7 | 7440-41-7 | Germany | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Other | 19/12/2016 | Details | |
202-859-9 | 100-51-6 | Germany | Carcinogenic Mutagenic Respiratory sensitiser STOT RE Toxic for reproduction | Under development | Under development | No suggestion yet | 24/06/2020 | Details | |
205-916-6 | 207-08-9 | Germany | Bioaccumulation Carcinogenic Mutagenic Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 05/07/2017 | Details | |
205-883-8 | 191-24-2 | Germany | Bioaccumulation Carcinogenic Mutagenic Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 05/07/2017 | Details | |
200-280-6 | 56-55-3 | Germany | Bioaccumulation Carcinogenic Mutagenic Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 05/07/2017 | Details | |
287-477-0 | 85535-85-9 | Germany | Carcinogenic Endocrine disruption Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 19/10/2020 | Details | |
203-466-5 | 107-13-1 | Germany | Mutagenic Other human toxicity Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Other legislation | 23/09/2014 | Details | |
202-679-0 | 98-54-4 | Germany | Endocrine disruption Other human toxicity Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 10/10/2019 | Details | |
209-544-5 | 584-84-9 | Germany | Bioaccumulation Carcinogenic Mutagenic Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 10/10/2019 | Details | |
202-966-0 | 101-68-8 | Germany | Respiratory sensitiser Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
225-863-2 | 5124-30-1 | Germany | Respiratory sensitiser Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
Bisphenol A; BPA | 201-245-8 | 80-05-7 | Germany | Aggregated tonnage Endocrine disruption Widespread use | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 15/08/2017 | Details |
223-861-6 | 4098-71-9 | Germany | Carcinogenic Exposure Mutagenic Other human toxicity | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 10/10/2019 | Details | |
202-112-7 | 91-97-4 | Germany | Mutagenic Persistence Respiratory sensitiser Skin sensitiser Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
202-039-0 | 91-08-7 | Germany | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
219-470-5 | 2440-22-4 | Germany | Other human toxicity Persistence Toxic for reproduction | Under development | Under development | No suggestion yet | 05/12/2014 | Details | |
603-051-2 | 125304-04-3 | Germany | Bioaccumulation Other human toxicity Persistence | Under development | Under development | No suggestion yet | 01/04/2015 | Details | |
253-037-1 | 36437-37-3 | Germany | Bioaccumulation Persistence | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 10/07/2015 | Details | |
221-573-5 | 3147-75-9 | Germany | Bioaccumulation Other environmental toxicity Persistence | Under development | Under development | No suggestion yet | 05/12/2014 | Details | |
274-570-6 | 70321-86-7 | Germany | Endocrine disruption Persistence | Under development | Under development | No suggestion yet | 05/12/2014 | Details | |
422-600-5 | - | Germany | Bioaccumulation Other environmental toxicity Persistence | Under development | Under development | No suggestion yet | 05/12/2014 | Details | |
223-383-8 | 3864-99-1 | Germany | Bioaccumulation Carcinogenic Mutagenic Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 10/07/2015 | Details | |
219-799-4 | 2536-05-2 | Germany | Respiratory sensitiser Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
3-benzylidene camphor; 3-BC | 239-139-9 | 15087-24-8 | Germany | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 10/07/2015 | Details |
221-641-4 | 3173-72-6 | Germany | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 10/10/2019 | Details | |
204-661-8 | 123-91-1 | Germany | Bioaccumulation Persistence | Concluded | Appropriate to initiate regulatory risk management action | SVHC Restriction | 23/06/2020 | Details | |
211-463-5 | 646-06-0 | Germany | Carcinogenic Mutagenic Respiratory sensitiser STOT RE Toxic for reproduction | Under development | Under development | No suggestion yet | 24/06/2020 | Details | |
220-474-4 | 2778-42-9 | Germany | Respiratory sensitiser Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
253-242-6 | 36861-47-9 | Germany | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 10/07/2015 | Details | |
701-028-2 | - | France | Endocrine disruption Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | SVHC Other | 24/05/2019 | Details | |
204-112-2 | 115-86-6 | France | Endocrine disruption Skin sensitiser | Concluded | No need to initiate further regulatory risk management action at this time | Other | 11/09/2019 | Details | |
202-924-1 | 101-20-2 | France | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | Other | 10/08/2018 | Details | |
201-067-0 | 77-90-7 | France | Endocrine disruption | Concluded | No need to initiate further regulatory risk management action at this time | None | 07/11/2016 | Details | |
201-071-2 | 77-94-1 | France | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | Other legislation | 22/01/2019 | Details | |
260-830-6 | 57583-54-7 | France | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | Other | 10/08/2018 | Details | |
246-563-8 | 25013-16-5 | France | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 17/01/2019 | Details | |
202-830-0 | 100-21-0 | France | Endocrine disruption | Concluded | No need to initiate further regulatory risk management action at this time | None | 07/03/2017 | Details | |
- | - | France | Carcinogenic Mutagenic Other human toxicity Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 28/01/2020 | Details | |
201-581-5 | 85-01-8 | France | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 13/10/2017 | Details | |
205-391-3 | 140-01-2 | France | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | CLH | 01/04/2016 | Details | |
247-421-8 | 26038-87-9 | France | Endocrine disruption Other human toxicity Persistence | Under development | Under development | No suggestion yet | 23/09/2014 | Details | |
232-104-9 | 7786-81-4 | France | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Other legislation | 02/02/2017 | Details | |
234-323-5 | 11099-02-8 | France | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Other legislation | 02/02/2017 | Details | |
236-068-5 | 13138-45-9 | France | Carcinogenic Mutagenic Toxic for reproduction | Under development | Under development | No suggestion yet | 23/09/2014 | Details | |
235-008-5 | 12054-48-7 | France | Carcinogenic Mutagenic Toxic for reproduction | Under development | Under development | No suggestion yet | 23/09/2014 | Details | |
231-743-0 | 7718-54-9 | France | Carcinogenic Mutagenic Toxic for reproduction | Under development | Under development | No suggestion yet | 23/09/2014 | Details | |
242-522-3 | 18718-11-1 | France | Carcinogenic Mutagenic Toxic for reproduction | Under development | Under development | No suggestion yet | 23/09/2014 | Details | |
200-652-8 | 67-43-6 | France | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | CLH | 01/04/2016 | Details | |
204-260-8 | 118-56-9 | France | Endocrine disruption Respiratory sensitiser Skin sensitiser | Concluded | No need to initiate further regulatory risk management action at this time | Other | 03/05/2019 | Details | |
200-001-8 | 50-00-0 | France | Carcinogenic Mutagenic Toxic for reproduction | Under development | Under development | No suggestion yet | 04/08/2016 | Details | |
231-892-1 | 7775-27-1 | France | Respiratory sensitiser Skin sensitiser Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | Other legislation | 09/03/2020 | Details | |
231-781-8 | 7727-21-1 | France | Respiratory sensitiser Skin sensitiser | Concluded | No need to initiate further regulatory risk management action at this time | Other legislation | 12/03/2020 | Details | |
231-786-5 | 7727-54-0 | France | Respiratory sensitiser Skin sensitiser | Concluded | No need to initiate further regulatory risk management action at this time | Other legislation | 09/03/2020 | Details | |
229-176-9 | 6422-86-2 | France | Carcinogenic Endocrine disruption Mutagenic Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 25/01/2019 | Details | |
201-469-6 | 83-32-9 | France | Carcinogenic Mutagenic Toxic for reproduction | Under development | Under development | No suggestion yet | 11/12/2015 | Details | |
235-715-9 | 12607-70-4 | France | Carcinogenic Mutagenic Toxic for reproduction | Under development | Under development | No suggestion yet | 23/09/2014 | Details | |
217-533-1 | 1879-09-0 | France | Carcinogenic Mutagenic Skin sensitiser Toxic for reproduction | Under development | Under development | No suggestion yet | 07/03/2017 | Details | |
226-378-9 | 5384-21-4 | France | Endocrine disruption Persistence Toxic for reproduction Widespread use | Under development | Under development | No suggestion yet | 11/03/2016 | Details | |
Bisphenol A; BPA | 201-245-8 | 80-05-7 | France | Endocrine disruption Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 15/08/2017 | Details |
201-025-1 | 77-40-7 | France | Endocrine disruption | Under development | Under development | No suggestion yet | 07/03/2017 | Details | |
Route: .live1